
8-Bromo-1-naphthoic acid | CAS:1729-99-3
8-Bromo-1-naphthoic acid
- 名称:8-溴-1-萘甲酸 | 8-Bromo-1-naphthoic acid
- CAS号:1729-99-3
- 别名:
- 分子式:C11H7BrO2
- 分子量:251.08
- EINESC号:217-045-9
产品描述
物理化学性质
熔点 | 169-171 ºC |
---|
安全数据
安全说明书 | S24/25 |
---|
产品合成路线
名称 | CAS号 |
---|
更多
文章
同行评议文献
The evaluation of ozone and betahistine in the treatment of tinnitus.Onur Sönmez et al.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 270(7), 1999-2006 (2012-10-27)
Betahistine or Cinnarizine for treatment of Meniere's disease.Jasminka Djelilovic-Vranic et al.Medical archives (Sarajevo, Bosnia and Herzegovina), 66(6), 396-398 (2013-02-16)
[Vertigo: patient management tactics].I S Vasyl'chuk et al.Likars'ka sprava, (7)(7), 84-87 (2013-01-29)
Betahistine dihydrochloride or betahistine mesilate: two sides of the same coin or two different coins.Hazra A, et al. International Journal of Basic & Clinical Pharmacology, 6(8), 1833-1840 (2017)
Transdermal delivery of betahistine hydrochloride using microemulsions: physical characterization, biophysical assessment, confocal imaging and permeation studies.Rania M Hathout et al.Colloids and surfaces. B, Biointerfaces, 110, 254-260 (2013-06-05)
Effect of transtympanic low-pressure therapy in patients with unilateral Menière's disease unresponsive to betahistine: a randomised, placebo-controlled, double-blinded, clinical trial.R Gürkov et al.The Journal of laryngology and otology, 126(4), 356-362 (2012-03-01)
[Clinical effectiveness and safety of sanchi tong shu capsule in the treatment of aural vertigo: a multi-center randomized controlled clinical trial].Juan Meng et al.Lin chuang er bi yan hou tou jing wai ke za zhi = Journal of clinical otorhinolaryngology, head, and neck surgery, 26(7), 295-299 (2012-06-29)
Bayesian model selection techniques as decision support for shaping a statistical analysis plan of a clinical trial: an example from a vertigo phase III study with longitudinal count data as primary endpoint.Christine Adrion et al.BMC medical research methodology, 12, 137-137 (2012-09-12)
[Efficacy of vestibo in the treatment of vertebrobasilar insufficiency].E I Chukanova et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(4), 53-56 (2012-07-20)
Comparison of the therapeutic efficacy of a fixed low-dose combination of cinnarizine and dimenhydrinate with betahistine in vestibular neuritis: a randomized, double-blind, non-inferiority study.Arne-Wulf Scholtz et al.Clinical drug investigation, 32(6), 387-399 (2012-04-18)
Histamine and antipsychotic drug-induced weight gain.Gavin P Reynolds Journal of psychopharmacology (Oxford, England), 26(12), 1608-1609 (2012-11-30)
Reducing antipsychotic-induced weight gain in schizophrenia: a double-blind placebo-controlled study of reboxetine-betahistine combination.Michael Poyurovsky et al.Psychopharmacology, 226(3), 615-622 (2012-12-15)
Effect of a fixed combination of nimodipine and betahistine versus betahistine as monotherapy in the long-term treatment of Ménière's disease: a 10-year experience.D Monzani et al.Acta otorhinolaryngologica Italica : organo ufficiale della Societa italiana di otorinolaringologia e chirurgia cervico-facciale, 32(6), 393-403 (2013-01-26)
Menière-like syndrome in Camurati-Engelmann disease.Lea Pollak The Israel Medical Association journal : IMAJ, 15(7), 390-391 (2013-08-16)
Effect of standard-dose Betahistine on endolymphatic hydrops: an MRI pilot study.R Gürkov et al.European archives of oto-rhino-laryngology : official journal of the European Federation of Oto-Rhino-Laryngological Societies (EUFOS) : affiliated with the German Society for Oto-Rhino-Laryngology - Head and Neck Surgery, 270(4), 1231-1235 (2012-07-05)
Histamine H4 receptor antagonists as potent modulators of mammalian vestibular primary neuron excitability.G Desmadryl et al.British journal of pharmacology, 167(4), 905-916 (2012-05-26)
Looks vestibular: irrational prescribing of antivertiginous drugs for older dizzy patients in general practice.Otto R Maarsingh et al.The British journal of general practice : the journal of the Royal College of General Practitioners, 62(603), 518-520 (2012-12-26)
[The effect of betahistine on histological changes in rabbit brain in model of whole body wide-frequency vibration].Iu Iu Shimkus et al.Eksperimental'naia i klinicheskaia farmakologiia, 76(6), 14-17 (2013-09-06)
Meniere's disease: an evidence based approach to assessment and management.I Syed et al.International journal of clinical practice, 66(2), 166-170 (2012-01-20)
Effectiveness of the combined hearing and masking devices on the severity and perception of tinnitus: a randomized, controlled, double-blind study.Isilay Oz et al.ORL; journal for oto-rhino-laryngology and its related specialties, 75(4), 211-220 (2013-08-01)
Benign paroxysmal positional vertigo (BPPV): influence of pharmacotherapy and rehabilitation therapy on patients' recovery rate and life quality.Sinisa Maslovara et al.NeuroRehabilitation, 31(4), 435-441 (2012-12-13)
Involvement of histamine receptors in SAPK/JNK phosphorylation.Radhika D Dandekar et al.International immunopharmacology, 13(2), 190-196 (2012-04-11)
Reducing olanzapine-induced weight gain side effect by using betahistine: a study in the rat model.Chao Deng et al.Journal of psychopharmacology (Oxford, England), 26(9), 1271-1279 (2012-06-15)
[Treatment of vestibular vertigo and Ménière syndrome in outpatient clinics].E V Kostenko et al.Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova, 112(12), 36-40 (2013-02-08)
Betahistine exerts a dose-dependent effect on cochlear stria vascularis blood flow in guinea pigs in vivo.Fritz Ihler et al.PloS one, 7(6), e39086-e39086 (2012-06-30)
Vestibular rehabilitation with virtual reality in Ménière's disease.Adriana Pontin Garcia et al.Brazilian journal of otorhinolaryngology, 79(3), 366-374 (2013-06-08)
备注
Products protected by valid patents are not offered for sale in countries where the sale of such products constitutes a patent infringement and its liability is at buyer's risk.
Products currently covered by valid US Patents are offered for R&D use in accordance with 35 USC 271 +A13(1).
名称 | CAS号 |
---|

相关产品
相关资讯
问
热门标签
询 单
请 填 写 相 关 信 息
- 请填写产品名称!
- CAS号
- 请正确填写公司名称!
- 请正确填写联系人!
- 请正确填写联系电话!
- 请正确填写联系邮箱!
- 请描述您的问题!